A prognostic role of LIFR and its ligand (LIF) has been recognized across several human cancers (Christianson et al., 2021), but the importance of this pathway and its co-occurrence with a JAK1 mutation have never been explored in lymphoid malignancies. The gene discussed is JAK1; the disease is cancer.